SKI Market

A+| A| A-|

Indian Indices

Sensex

76,913.50 -582.86
( -0.75%)

Global Indices

Nasdaq

49,530.46 -142.69
(-0.29%)

Dow Jones

7,252.74 22.73
(0.31%)

Hang Seng

59,594.47 309.55
(0.52%)

Nikkei 225

10,375.34 -3.48
(-0.03%)

Forex

USD-INR

94.96 0.17
(0.17%)

EUR-INR

111.11 0.25
(0.23%)

GBP-INR

128.48 0.55
(0.43%)

JPY-INR

0.60 0.01
(1.28%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

CCL Products (India) Ltd

Industry : Tea

BSE Code

ISIN Demat

Book Value()

519600

INE421D01022

94.7170587

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

CCL

72.14

15152.75

EPS(TTM)

Face Value()

Div & Yield %

15.73

0.44

Back

Ishita Drugs & Industries standalone net profit declines 26.32% in the September 2025 quarter

Nov 12,2025

Net profit of Ishita Drugs & Industries declined 26.32% to Rs 0.14 crore in the quarter ended September 2025 as against Rs 0.19 crore during the previous quarter ended September 2024. Sales declined 6.12% to Rs 3.07 crore in the quarter ended September 2025 as against Rs 3.27 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	3.07	3.27	-6
OPM %	5.86	7.03	-
PBDT	0.25	0.28	-11
PBT	0.22	0.25	-12
NP	0.14	0.19	-26

76,913.50 -582.86 ( -0.75%)

49,530.46 -142.69 (-0.29%)

7,252.74 22.73 (0.31%)

59,594.47 309.55 (0.52%)

10,375.34 -3.48 (-0.03%)

94.96 0.17 (0.17%)

111.11 0.25 (0.23%)

128.48 0.55 (0.43%)

0.60 0.01 (1.28%)